IndermRetcin en es it fr

IndermRetcin Brand names, IndermRetcin Analogs

IndermRetcin Brand Names Mixture

  • No information avaliable

IndermRetcin Chemical_Formula


IndermRetcin RX_link

No information avaliable

IndermRetcin fda sheet

IndermRetcin msds (material safety sheet)

IndermRetcin Synthesis Reference

No information avaliable

IndermRetcin Molecular Weight

167.205 g/mol

IndermRetcin Melting Point

96 oC

IndermRetcin H2O Solubility

2500 mg/L

IndermRetcin State


IndermRetcin LogP


IndermRetcin Dosage Forms

No information avaliable

IndermRetcin Indication

Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.

IndermRetcin Pharmacology

Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.

IndermRetcin Absorption

Rapidly absorbed following oral administration.

IndermRetcin side effects and Toxicity

Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.

IndermRetcin Patient Information

IndermRetcin Organisms Affected

Humans and other mammals